计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab176090-100μg |
100μg |
现货 ![]() |
| |
| Ab176090-1mg |
1mg |
现货 ![]() |
| |
| Ab176090-5mg |
5mg |
现货 ![]() |
| |
| Ab176090-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Ianalumab (anti-TNFRSF13C), 肿瘤坏死因子受体超家族成员 13C 结合剂的结合剂 |
|---|---|
| 别名 | 伊利尤单抗 | 伊那鲁单抗(抗肿瘤坏死因子生长因子受体13C) |
| 英文别名 | B cell activating factor receptor antibody | B-cell-activating factor receptor antibody | BAFF R antibody | BAFF receptor antibody | BAFF-R antibody | BAFFR antibody | BLyS receptor 3 antibody | BlySR3 antibody | BR 3 antibody | BR3 antibody | BROMIX anti |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | TNFRSF13C |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 作用类型 | 结合剂 |
| 作用机制 | 肿瘤坏死因子受体超家族成员 13C 结合剂的结合剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 26.8 kDa (Light Chain) & 52.1 kDa (Heavy Chain), under reducing conditions; 182.4 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1929549-92-7 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Ianalumab (anti-TNFRSF13C) (Ab176090) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling TNFRSF13C (red) with Ianalumab (anti-TNFRSF13C) (Ab176090). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Ianalumab (anti-TNFRSF13C) (Ab176090) - SEC
The purity of Ianalumab (anti-TNFRSF13C) (Ab176090) is more than 95% verified by HPLC.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab176090 | |
| 分析证书 | Ab176090 | |
| 分析证书 | Ab176090 | |
| 分析证书 | Ab176090 | |
| 分析证书 | Ab176090 |
| 1. Dunham, I I and 24 more authors.. (1999) The DNA sequence of human chromosome 22.. Nature, (2): [PMID:10591208] |
| 2. Thompson, J S JS and 15 more authors.. (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.. Science (New York, N.Y.), (14): [PMID:11509692] |
| 3. Yan, M M and 8 more authors.. (2001) Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.. Current biology : CB, (2): [PMID:11591325] |
| 4. Kayagaki, Nobuhiko N and 11 more authors.. (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.. Immunity, [PMID:12387744] |
| 5. Kim, Ho Min HM and 8 more authors.. (2003) Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.. Nature structural biology, [PMID:12715002] |
| 6. Liu, Yingfang Y and 11 more authors.. (2003) Ligand-receptor binding revealed by the TNF family member TALL-1.. Nature, (1): [PMID:12721620] |
| 7. Gordon, Nathaniel C NC and 9 more authors.. (2003) BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.. Biochemistry, (27): [PMID:12755599] |
| 8. Losi, Claretta Gioia CG and 8 more authors.. (2005) Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency.. Journal of clinical immunology, [PMID:16160919] |
| 9. Lee, Chingwei V CV and 13 more authors.. (2006) Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.. Blood, (1): [PMID:16840730] |
| 10. Warnatz, Klaus K and 13 more authors.. (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.. Proceedings of the National Academy of Sciences of the United States of America, (18): [PMID:19666484] |